Epidemiology and prevention of arterial hypertension in Poland

Blood Pressure

Volumn 14, Issue SUPPL. 2, 2005, Pages 10-16

  Zdrojewski, Tomasz ^a,c   Wyrzykowski, Bogdan ^a   Szczech, R ^c   Wierucki, Lukasz ^a   Naruszewicz, Marek ^b   Narkiewicz, K ^c   Zarzeczna Baran, Marzena ^a   Bandosz, P ^c   Szpakowski, P ^c   Konarski, R ^c   Manikowski, A ^c   Wolkiewicz, E ^c   Jakubowski, Z ^c   Lysiak Szydlwska, S ^c   Bautembach, S ^c   Kozlowska Wojciechowska, M ^c   Nowicka, G ^c   Klosiewicz Latoszek, L ^c   Jarosz, M ^c   Tylka, J ^c   Makarewicz Wujec, M ^c   Szyndler, A ^c   Popowski, P ^c   Medras M ^c   Makarewicz, W ^c   Grodzicki, T ^c   Wizner, B ^c   Januszewicz, A ^c   Drygas, W ^c   Slonska Z ^c   Piwonski J ^c   Gluszek, J ^c   Tykarski, A ^c   Zatonski W ^c   Opolski, G ^c   more..

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NATIONAL FOOD AND NUTRITION INSTITUTE   (Poland)

^c NONE

Author keywords

Awareness; Education; Epidemiology; Hypertension; Marketing; Prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; EDUCATION PROGRAM; GEOGRAPHIC DISTRIBUTION; GOVERNMENT; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE; MASS SCREENING; OBESITY; POLAND; POPULATION DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; STROKE; CHILD; REVIEW;

ADULT; CHILD; HEALTH EDUCATION; HUMANS; HYPERTENSION; MASS SCREENING; POLAND; RISK FACTORS;

EID: 31744441986     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08038020500429052     Document Type: Article

References (18)

1. Kannel, W. B. (2003) Prevalence and implications of uncontrolled systolic hypertension. Drugs Aging, 20, pp. 277 - 286.
2. Hajjar, I. and Kotchen, T. A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290, pp. 199 - 206.
3. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. (1988) WHO MONICA Project Principal Investigators. J Clin Epidemiol, 41, pp. 105 - 14.
4. Rywik, S. and Wagrowska, H. and Broda, G. and Kuzminska, A. and Polakowska, M. and Kulesza, W. and (1989) Epidemiology of cardiovascular diseases in Warsaw Pol-MONICA area. Int J Epidemiol, 18((3 Suppl 1)), pp. S129 - S136.
5. Bovet, P. and Gervasoni, J. P. and Ross, A. G. and Mkaba, M. and Mtasiwa, D. M. and Lengeler, Ch. and (2003) Assessing the prevalence of hypertension in populations: Are we doing it right? J Hypertens, 21, pp. 509 - 517.
6. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (1997) Arch Intern Med, 157, pp. 2413 - 2446.
7. Zdrojewski, T. and Szpakowski, P. and Bandosz, P. and Pajak, A. and Wiecek, A. and Krupa-Wojciechowska, B. and (2004) Arterial hypertension in Poland in 2002. J Hum Hypertens, 18, pp. 557 - 562.
8. Primatesta, P. and Brookes, M. and Poulter, N. R. (2001) Improved hypertension management and control: Results from the health survey for England 1998. Hypertension, 38, pp. 827 - 832.
9. Chamontin, B. and Poggi, L. and Lang, T. and Menard, J. and Chevalier, H. and Gallois, H. and (1998) Prevalence, treatment, and control of hypertension in the French population: Data from a survey on high blood pressure in general practice, 1994. Am J Hypertens, 11((6 Pt 1)), pp. 759 - 762.
10. Banegas, J. R. and Rodriguez-Artalejo, F. and de la Cruz Troca, J. J. and Guallar-Castillon, P. and del Rey Calero, J. (1998) Blood pressure in Spain: Distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension, 32, pp. 998 - 1002.
11. Joffres, M. R. and Ghadirian, P. and Fodor, J. G. and Petrasovits, A. and Chockalingam, A. and Hamet, P. (1997) Awareness, treatment, and control of hypertension in Canada. Am J Hypertens, 10((10 Pt 1)), pp. 1097 - 1102.
12. Wolf-Maier,. K. and Cooper, R. S. and Kramer, H. and Banegas, J. R. and Giampaoli, S. and Joffers, M. R. and (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension, 43, pp. 10 - 17.
13. Wolf-Maier, K. and Cooper, R. S. and Gampaoci, S. and Hense, H. W. and Joffers, M. and Banegas, J. R. and et al (2003) Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA, 289, pp. 2363 - 2369.
14. Zdrojewski, T. and Głuszek, J. and Posadzy-Małaczyńska, A. and Drygas, W. and Ornoch-Tabedzka, M. and Januszko, W. and (2004) [The effects of community intervention on detection of and efficacy of treatment for arterial hypertension. Main results of the Polish Four Cities Programme]. Kardiol Pol, 61, pp. 546 - 558.
15. Zdrojewski, T. and Rutkowski, M. and Zarzeczna-Baran, M. and Grodzicki, T. and Januszewicz, A. and Narkiewicz, K. and (2004) [National, multi-center cardiovascular diseases prevention program - Polish 400 Cities Project. Basic assumptions, objectives, execution]. Polski Przegla̧d Kardiologiczny, 6, pp. 423 - 430.
16. Wierucki, Ł. and Zdrojewski, T. and Mogilnaya, I. and Zarzeczna-Baran, M. and Wizner, B. and Medras, M. and (2004) [The Polish 400 Cities Project - Results of the pilot survey]. NadciŚnienie Tȩtnicze, 8, pp. 307 - 317.
17. Chen, W. and Srinivasan, S. R. and Li, S. and Xu, J. and Berenson, G. S. (2005) Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: The Bogalusa Heart Study. Diabetes Care, 28, pp. 126 - 131.
18. Zdrojewski, T. and Babińska, Z. and Ka̧kol, M. and Januszko, W. and Bandosz, D. and Mogilnaya, J. and (2003) Pomiary czynników ryzyka chorób układu kra̧zenia w polskich środowiskach politycznych i opiniotwórczych jako konstruktywny lobbing na rzecz skutecznego zapobiegania chorobom układu kra̧enia. Nadciśnienie Tȩtnicze, pp. 235 - 244.